Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 38, 2008 - Issue 10
59
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Increased transendothelial permeability of anti-cancer agent carboplatin with the aid of hyperbaric oxygenation

, , , , &
Pages 1298-1304 | Received 07 Jun 2008, Accepted 13 Aug 2008, Published online: 16 Oct 2008

References

  • Allen JC, Walker R, Luks E, Jennings M, Barfoot S, Tan C. Carboplatin and recurrent childhood brain tumors. Journal of Clinical Oncology 1987; 5: 459–463
  • Al-Waili NS, Butler GJ. A combination of radiotherapy, nitric oxide and a hyperoxygenation sensitizing protocol for brain malignant tumor treatment. Medical Hypotheses 2007; 68: 528–537
  • Cecchelli R, Dehouck B, Descamps L, Fenart L, Buee-Scherrer V, Duhem C, Lundquist S, Rentfel M, Torpier G, Dehouck MP. In vitro model for evaluating drug transport across the blood–brain barrier. Advanced Drug Delivery Reviews 1999; 36: 165–178
  • Chougule PB, Akhtar MS, Akerley W, Ready N, Safran H, McRae R, Nigri P, Bellino J, Koness J, Radie-Keane K, et al. Chemoradiotherapy for advanced inoperable head and neck cancer: A phase II study. Seminars in Radiation Oncology 1999; 9(2 Suppl. 1)58–63
  • Crofton KM, Makris SL, Sette WF, Mendez E, Raffaele KC. A qualitative retrospective analysis of positive control data in developmental neurotoxicity studies. Neurotoxicology and Teratology 2004; 26: 345–352
  • Culot M, Lundquist S, Vanuxeem D, Nion S, Landry C, Delplace Y, Dehouck MP, Berezowski V, Fenart L, Cecchelli R. An in vitro blood–brain barrier model for high throughput (HTS) toxicological screening. Toxicology in Vitro 2008; 22: 799–811
  • Dehouck MP, Meresse S, Delorme P, Fruchart JC, Cecchelli R. An easier, reproducible, and mass-production method to study the blood–brain barrier in vitro. Journal of Neurochemistry 1990; 54: 1798–1801
  • Gottesman MM, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annual Reviews of Biochemistry 1993; 62: 385–427
  • Kalns J, Krock L, Piepmeier Jr E. The effect of hyperbaric oxygen on growth and chemosensitivity of metastatic prostate cancer. Anticancer Research 1998; 18: 363–367
  • Rump AF, Siekmann U, Kalff G. Effects of hyperbaric and hyperoxic conditions on the disposition of drugs: Theoretical considerations and a review of the literature. General Pharmacology 1999; 32: 127–133
  • Sarkadi B, Price EM, Boucher RC, Germann UA, Scarborough GA. Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase. Journal of Biological Chemistry 1992; 267: 4854–4858
  • Tanaka K, Yoshida Y, Hashimoto T, Gamura S, Shimizu M, Aoyama T, Yamazaki H. Pharmacokinetics of anti-cancer drug with hyperbaric oxygenation therapy. Neuro-Oncology 2005; 15: 7–10, [in Japanese]
  • Tanaka K, Yoshida Y, Hashimoto T, Suga M, Yoshida K. Statistical study of chemotherapy for malignant gliomas. Neuro-Oncology 2004; 14: 15–18, [in Japanese]
  • Yamazaki H, Tanaka K, Gamura S, Hashimoto T, Shimizu M. High-performance liquid chromatographic assay for carboplatin in ultrafiltered plasma combined with hyperbaric oxygenation. Drug Metabolism and Pharmacokinetics 2006; 21: 429–431
  • Zhao P, Dash AK. A simple HPLC method using a microbore column for the analysis of doxorubicin. Journal of Pharmaceutical and Biomedical Analysis 1999; 20: 543–548

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.